Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: dino who wrote (4677)	7/6/1998 12:28:00 AM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

Interesting, Dino. The thing is that seems to happen with all the drugs after they are out a while. If Viagra's effectiveness is dropped from 70% to 50%, then Vasomax's would also drop from the top effectiveness expected (50%?), to a similar amount. That would bring it down to what? I forget, actually? 30-35%? Similarly, after drugs have been in use for a while more side effects can appear, so the same would happen with Vasomax, yes? It will be interesting to see if ZONA does go up on Viagra's weakness, because the issue to me is that Vasomax really doesn't work in the first place. If Vasomax doesn't work, Viagra could be even ineffective and it still won't help Vasomax to sell. Thanks a LOT for the news! Linda